The study is built around a concept scientists call the social exposome: the cumulative sum of social and environmental factors that a person encounters from birth onward. Rather than focusing on a single risk factor in isolation, the researchers examine how poverty, education, housing, employment, and exposure to toxins accumulate and interact over a lifetime to shape brain health. The central premise is that dementia risk is not determined solely by genes or by individual lifestyle choices, but also by the structural and environmental conditions in which people are embedded for decades before symptoms appear.

What distinguishes The Neighborhoods Study from other large dementia research programs is its scale and its unusual reach into biology. It is the largest study in the world to connect the social exposome with actual brain tissues and their disease biomarkers. This means the project does not stop at survey data or neighborhood statistics; it links lifelong exposure histories to measurable changes in the brain, including the molecular hallmarks of Alzheimer’s disease and related dementias that can be detected in tissue. By bridging the social sciences and neuropathology, the collaboration aims to uncover the precise mechanisms by which adverse environments translate into neurodegeneration.

With the renewed funding, the investigators will expand their focus to several specific exposure domains. The next phase of research will assess lead-contaminated infrastructure exposure, job-related toxin exposures that people accumulate throughout their working lives, and the presence of heavy metals in brain tissue. These lines of inquiry are designed to clarify what makes certain populations especially vulnerable to Alzheimer’s disease and related dementias, and to determine whether toxic exposures that vary by occupation, housing quality, and geography leave detectable signatures in the brain that correlate with disease outcomes.

Allan Levey, MD, PhD, director of the Emory Goizueta Alzheimer’s Disease Research Center and executive director of the Emory Goizueta Brain Health Institute, emphasized the preventive promise of the work. By examining how social and environmental factors accumulate across the lifespan and influence brain health, he said, researchers have an important opportunity to identify ways to reduce risk and to develop more effective and equitable approaches to prevention. He described the study as the kind of collaborative, interdisciplinary research that is essential to understanding and ultimately preventing Alzheimer’s disease and related dementias, and noted that Emory is proud to contribute to the national effort through its Alzheimer’s Disease Research Center.

Felicia Goldstein, PhD, professor of neurology at Emory University, co-lead of the Clinical Core of the Emory Alzheimer’s Disease Research Center, and Emory site principal investigator for The Neighborhoods Study, highlighted the scientific value of connecting lived experience to brain biology. She said the research offers an important opportunity to understand how the environments in which people live and work over the course of their lives can influence brain health and dementia risk. By linking these lifelong exposures with brain changes and disease biomarkers, she explained, the team can move closer to identifying the populations at greatest risk and developing more precise strategies for prevention and risk reduction.

The renewed award builds on substantial achievements from the study’s first phase, which was initiated in 2021. That phase supported the continued development of the Area Deprivation Index, a tool created at the University of Wisconsin’s Center for Health Disparities Research that ranks neighborhoods by socioeconomic disadvantage. The ADI has since been used to develop thousands of health interventions and policies aimed at achieving better health outcomes for people living in rural and urban neighborhoods with the greatest need, making it one of the most widely applied measures of neighborhood disadvantage in American health research.

The first phase of The Neighborhoods Study also produced important scientific findings in its own right. The researchers demonstrated an association between neighborhood disadvantage, as measured by the Area Deprivation Index, and increased odds of neurodegeneration, Alzheimer’s disease biomarkers, and post-mortem neuropathology of the disease. They further linked residency in high-ADI neighborhoods across a person’s lifetime with increased risk of neurodegeneration and brain disease. Together, these results suggest that the cumulative burden of living in disadvantaged environments is written into the brain itself, visible both in biomarkers during life and in pathological changes after death.

Looking ahead, the study is expected to facilitate prevention measures for Alzheimer’s disease and related dementias that are precisely tailored to the populations at highest risk based on their specific exposure profiles. Rather than offering generic advice, such tailored interventions could target the particular environmental hazards and social conditions that drive risk in a given community, whether those involve lead-contaminated water systems, occupational toxin exposure, or concentrated neighborhood poverty. The work focuses on risk mitigation and the development of new interventions, advancing knowledge of the relationship between the exposome and dementia in order to improve health for all.

The significance of the effort extends beyond any single institution. Alzheimer’s disease and related dementias represent one of the largest and fastest-growing public health challenges of an aging global population, and decades of research have shown that no single cause explains the majority of cases. By coordinating twenty-four research centers under a common framework and tying social data to brain tissue analysis, The Neighborhoods Study offers a model for how large-scale, interdisciplinary science can address complex diseases whose roots lie partly in the social and physical world. For the Emory Goizueta Brain Health Institute, which is dedicated to advancing innovation in brain health prediction, prevention, and treatment, participation in the study reflects its broader mission to uncover the mechanisms of brain disease and to develop therapeutic strategies and biomarkers that can change the trajectory of dementia for the communities most affected.

Subject of Research: The relationship between lifelong social and environmental exposures and Alzheimer's disease risk

Article Title: Emory Goizueta Brain Health Institute part of nationwide NIH study on links between environmental factors and Alzheimer's disease

Article References: Emory Goizueta Brain Health Institute part of nationwide NIH study on links between environmental factors and Alzheimer's disease. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Alzheimer's disease, social exposome, NIH funding, neighborhood disadvantage, Area Deprivation Index, dementia prevention, brain biomarkers, heavy metals, lead exposure, Emory University, neurodegeneration, public health

The study, led by researchers including Agustin Ibanez, Professor in Brain Health at the Global Brain Health Institute and School of Medicine at Trinity College Dublin, analysed 2,928 Spanish-speaking participants drawn from Argentina, Chile, Colombia, Mexico, and Peru. The cohort was deliberately broad, including healthy adults as well as people living with mild cognitive impairment, Alzheimer’s disease, and different forms of frontotemporal dementia. This diversity allowed the team to test whether speech-derived aging signals were meaningful not only in typical aging but also across the spectrum of neurodegenerative disease, and to do so in a region that has historically been underrepresented in dementia research.

Technically, the approach departs sharply from earlier voice-based studies that isolated a single property of speech, such as average pitch or speaking rate. Instead, the researchers extracted hundreds of features capturing both how people speak and what they say. On the acoustic side, these included speech rate, the distribution and length of pauses, pitch characteristics, and the emotional content carried in the voice. On the linguistic side, the features encompassed vocabulary, semantic precision, and the amount and organisation of verbal output. Machine-learning models then combined this high-dimensional feature set to produce an estimate of chronological age, and the difference between that estimate and a person’s true age defined the individual’s speech age gap.

The central finding is that this gap is not mere statistical noise. People whose speech sounded older than their chronological age also showed signs of accelerated aging across several biological and clinical systems. The speech age gap was associated with brain age measured through structural and functional neuroimaging, meaning that individuals with older-sounding voices tended to have brains whose imaging signatures also appeared older than expected. It was also related to epigenetic aging, assessed with three independent DNA-methylation clocks, which estimate how biologically old the body appears based on age-related chemical changes accumulated in DNA. Convergence across such heterogeneous measures, from voice acoustics to molecular methylation patterns, is what gives the result its weight.

Cognition provided another line of evidence. Greater speech-age acceleration was associated with poorer global cognition, reduced executive function, diminished functional abilities, and impairment across several forms of memory. Importantly, these relationships were not confined to language-based tests, which might have been expected to share method variance with a speech-derived measure. Speech age also correlated with performance on non-linguistic cognitive measures, suggesting that the signal reflects something broader about neural integrity rather than simply capturing vocabulary size or verbal fluency in a circular fashion.

The clock also proved sensitive to clinical status. Healthy participants showed the lowest speech age gaps, while progressively larger gaps were observed across Alzheimer’s disease and the various forms of frontotemporal dementia. Notably, the complete speech-age measure discriminated clinical groups better than individual acoustic or linguistic features considered in isolation, an outcome that underscores the value of multivariate machine-learning approaches over single-marker analyses. Within Alzheimer’s disease specifically, the speech-derived measure was associated with higher levels of plasma p-tau217, one of the most important blood biomarkers of Alzheimer’s pathology, and it also tracked cognitive and clinical functioning. A measure requiring nothing more than a microphone converging with a leading fluid biomarker is a result that will attract attention across the dementia field.

Perhaps the most unexpected dimension of the findings is social. Among both healthy individuals and people with Alzheimer’s disease and other dementias, accelerated speech aging was associated with a more adverse social exposome, the cumulative combination of lifelong factors such as education, financial conditions, food insecurity, healthcare access, and early-life experiences. In other words, the voice did not only carry biological information; it appeared to register the accumulated imprint of social circumstances over a lifetime. This positions speech as a potential low-cost window into how social determinants of health become embodied in aging trajectories, a question of growing interest in population health research.

Our voice appears to contain much more information about aging than we previously recognised, said Ibanez, the study’s senior author. It captures both the passage of chronological time and signals coming from cognition, the brain, systemic biology, and even our accumulated social environment. This raises the possibility that something as simple and accessible as speech clocks, maybe combined with biomarkers, could eventually complement much more expensive measures of aging. The broader finding is nevertheless striking, he added, in that a person’s voice may provide a remarkably compact readout of multiple dimensions of aging, with information traditionally obtained through very different and often expensive measurements converging, at least partly, in the way we speak.

The practical implications are considerable. Many current measures of biological aging depend on MRI scanners, blood samples, molecular assays, or specialised clinical assessments, resources that are unevenly distributed across the world. Speech, by contrast, can be recorded remotely, repeatedly, non-invasively, and at very low cost, which could prove particularly important in countries and communities where advanced diagnostic technologies are difficult to access. Because the study was conducted across five Latin American countries, it also delivers a pointed message: sophisticated biomarkers of aging do not necessarily need to depend exclusively on expensive technologies developed in high-resource settings. If confirmed longitudinally and across populations, the researchers suggest, speech could ultimately become one of the most scalable tools for monitoring healthy and accelerated aging, potentially transforming an everyday human behaviour into a window onto the biology of aging.

Caution remains warranted, and the researchers are explicit about the limits of the current evidence. The speech clock is not yet a diagnostic test for dementia, and the study was primarily cross-sectional, meaning it cannot establish whether an older-appearing speech profile predicts who will subsequently develop cognitive decline or dementia. Longitudinal studies will be needed to determine whether speech age acceleration precedes clinical deterioration, and validation in additional languages and cultures, along with testing in more naturalistic speech settings, will be required before any clinical implementation. Even so, the convergence reported here, spanning neuroimaging, epigenetics, cognition, blood-based Alzheimer’s pathology, and social exposure, marks speech as one of the most intriguing candidate biomarkers to emerge in recent years, and one that requires nothing more exotic than a conversation.

Subject of Research: Machine-learning speech clocks that estimate chronological age and track biological aging, brain health, and dementia

Article Title: Your voice may reveal how fast and how well you’re aging – new research

Article References: Your voice may reveal how fast and how well you’re aging – new research. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: speech clock, biological aging, machine learning, dementia, Alzheimer's disease, epigenetic clocks, brain age, cognition, frontotemporal dementia, social exposome, p-tau217, Science Advances